Capricor Therapeutics, Inc.

Potential Vaccine Candidate Employs Novel Exosome- Based mRNA Delivery Platform that Induces Long-Lasting Immunity to Multiple SARS-CoV-2 Proteins! #CAPR #exsome #COVID19 #coronavirus >>Click the link to read full publication>> https://bit.ly/32pi9OD

Capricor Therapeutics Announces Positive Preclinical Data for Multivalent Exosome-mRNA Vaccine For COVID-19! #CAPR #exosome #COVID19 #coronavirus >> Click link to read full press release>>https://bit.ly/359OpXX

Capricor Therapeutics to Present Third Quarter 2020 Financial Results and Recent Corporate Update on November 12th at 4:30pm ET/ 1:30pm PT #CAPR >>Click the link to read full press release >> https://bit.ly/2HZgust

Capricor Therapeutics to Present Results from the HOPE-2 Trial with CAP-1002 in Duchenne Muscular Dystrophy at the International World Muscle Society Virtual Congress 2020! #CAPR #HOPE2 #wms2020 #CAP1002 >>> Click the link to read full press release>>>https://bit.ly/2G7sSoD

Reminder! Capricor Therapeutics to Present at H.C. Wainwright 22nd Annual Global Investment Conference on Today, at 10:30 AM ET / 7:30 AM PT! #CAPR Click the link to access the webcast >>https://bit.ly/2DQVbHf>>

Capricor Therapeutics to Present at H.C. Wainwright 22nd Annual Global Investment Conference on Tuesday, September 15, at 10:30 AM ET / 7:30 AM PT! #CAPR Click the link to access the webcast >>https://bit.ly/2DQVbHf>>

It's World Duchenne Awareness Day!! Help raise awareness and spread information about our fight to #EndDuchenne!

Reminder: Capricor Therapeutics to Present at The LD 500 Virtual Conference Today at 9:20 AM ET / 6:20 AM PT! #CAPR Click the link to access webcast>>https://bit.ly/2QH90Lc>>

Capricor Therapeutics to Present at The LD 500 Virtual Conference on Friday, September 4 at 9:20 AM ET / 6:20 AM PT! #CAPR Click the link to access webcast>>https://bit.ly/2QH90Lc>>

Capricor CEO Linda Marbàn was recently featured on PBS’ The White House Chronicle. Linda sat down with @LlewellynKing2 to discuss the exosomal path to developing a vaccine for COVID-19 and Duchenne Muscular Dystrophy, and the excitement of medical research. Click here to watch the full interview #CAPR #CAP1002 #Exosomes #PBS #COVID19

Capricor Therapeutics Announces U.S. FDA Acceptance of its IND Application for a Phase 2 Clinical Trial of CAP-1002 in Patients with COVID-19! #CAPR #COVID19 #Coronavirus >> Click here to read the full press release!>>https://bit.ly/3aXl7Nm

Tune into this PharmaVOICE WoW podcast interview to hear from our #client Dr. Linda Marbán CEO of Capricor Therapeutics, Inc. discuss the exciting new developments the Company is working on in first-in-class cell and exosome-based therapeutics: https://bit.ly/3gczH4O

Check out this PBS' The White House Chronicle segment featuring Dr. Linda Marbán CEO of Capricor Therapeutics, Inc., where she discusses with Llewellyn King the... exosomal path to developing a vaccine for COVID-19, Duchenne Muscular Dystrophy, and the excitement of medical research. Watch the full clip here: https://bit.ly/2PExX9D #PBS #Exosomes See more